Eclampsia: treatment and referral.
Although the recognition and treatment of preeclampsia theoretically should eliminate eclampsia, it has not disappeared and remains a substantial threat to maternal and fetal well-being. The therapy of choice for treatment and prevention of convulsions is magnesium sulfate (MgSO4 . 7H2O USP) and that for severe hypertension is intravenous hydralazine. Delivery of the fetus and placenta is recommended after the mother is stabilized from the effects of the convulsion(s). If the mother is to be transported before delivery, it is important that she receive an adequate dose of MgSO4.
D000293:Adolescent; D000328:Adult; D036861:Delivery, Obstetric; D004461:Eclampsia / Q000188:drug therapy*; D005260:Female; D006801:Humans; D006830:Hydralazine / Q000008:administration & dosage; D007226:Infant Mortality; D007231:Infant, Newborn; D007263:Infusions, Parenteral; D008278:Magnesium Sulfate / Q000627:therapeutic use*; D011225:Pre-Eclampsia / Q000188:drug therapy; D011247:Pregnancy; D012017:Referral and Consultation; D014187:Transportation of Patients
D006830:Hydralazine; D008278:Magnesium Sulfate